Live tape
Top 8, mentions 7d30,212NVDA14,254 mentions▲ +0.04ANT4,320 mentions▲ +0.07GOOGL3,151 mentions▲ +0.04SPY2,363 mentions▲ +0.05QQQ1,870 mentions▲ +0.04SPCX1,605 mentions▲ +0.07AMD1,389 mentions▲ +0.06AAPL1,260 mentions▲ +0.04

Equity · Healthcare

FATE

NASDAQ

Fate Therapeutics (FATE)

0.9246 USD −9.35% vs prior close Nov 20, 2026
Fate Therapeutics, Inc. price graph
63 sessions
3 0 24 Aug 20 Nov

The line runs 2.45 USD on 24 August through 0.9246 USD on 20 November, on a scale from 0 to 3. Days the market did not trade hold the previous close, flat.

Market cap
112.4M USD
Revenue, year to Dec 2025
6.6M USD
EPS, diluted, year to Dec 2025
−1.15 USD
52-week range
0.9246 USD – 3.11 USD
Avg volume
106.9K
Mentions, 30 days
1

as of Nov 20, 2026

Have Fate Therapeutics (FATE) insiders bought or sold shares recently?

In the 90 days to 23 Nov 2026, Fate Therapeutics insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 20 Oct 2025, show no open-market purchase.

Form 4, 90 days to 23 Nov 2026, newest reported trade 3 Nov 2026

0buys
1sells
$14Knet sold
0other filings
Have Fate Therapeutics (FATE) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
03 Nov 2026Adawi KamalChief Financial OfficerSell6,58214K USD

Which funds hold Fate Therapeutics (FATE)?

8 of the 45 institutional funds we track reported a Fate Therapeutics position for the quarter ended 30 Sep 2026 — a combined 25.2M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Fate Therapeutics (FATE)?
FundPositionSharesValueShares q/q
Two Sigma InvestmentsHeld (±25%)3,905,3579.3M USD+8.8%
Renaissance TechnologiesHeld (±25%)2,374,3945.6M USD−20.4%
Millennium ManagementHeld (±25%)2,167,5485.1M USD−10.9%
Citadel AdvisorsHeld (±25%)846,9202.0M USD−14.7%
Marshall WaceHeld (±25%)416,938988K USD−15.3%
Man GroupAdded368,205873K USD+109.1%
AQR Capital ManagementTrimmed352,086834K USD−90.8%
Point72 Asset ManagementTrimmed209,501497K USD−52.6%
Balyasny Asset ManagementExited

Have members of Congress traded Fate Therapeutics (FATE)?

The most recent congressional trade disclosed in Fate Therapeutics is a sale by Daniel S. Goldman (house, NY), dated 31 Jan 2023.

STOCK Act disclosures

Have members of Congress traded Fate Therapeutics (FATE)?
TradedMemberTypeAmountFiled after
31 Jan 2023Daniel S. Goldmanhouse · Democrat–NYSale1K USD–15K USD24 days

What has been filed or recorded for Fate Therapeutics (FATE)?

The filings we hold for Fate Therapeutics, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 29 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Fate Therapeutics (FATE)?
And
29 Oct 2026Fails to deliverShares failed to deliver475 shares1K USD notional · <0.001% of shares out
28 Oct 2026Fails to deliverShares failed to deliver1,012 shares2K USD notional · 0.001% of shares out
19 Oct 2026Fails to deliverShares failed to deliver220 shares394 USD notional · <0.001% of shares out
08 Oct 2026Fails to deliverShares failed to deliver1,977 shares4K USD notional · 0.002% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS −0.25 USD
30 Sep 2026FinancialsTotal assets238.3M USDat period end
30 Sep 2026FinancialsTotal equity133.0M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.25 USDRevenue $2M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.26 USDRevenue $1M
31 Dec 2025Annual reportFY 2025 reportedEPS −1.15 USDRevenue $7M
31 Dec 2025FinancialsRevenue6.6M USDfiscal year
31 Dec 2025FinancialsNet income−136.3M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−1.15 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.27 USDRevenue $2M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS −0.29 USDRevenue $2M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.32 USDRevenue $2M
31 Dec 2024Annual reportFY 2024 reportedEPS −1.64 USDRevenue $14M

What is Reddit saying about Fate Therapeutics (FATE)?

Reddit mentioned FATE 1 times in the 30 days to 22 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 22 November 2026.

30-day window, Method

1mentions, 30 days
1communities

How do Reddit mentions of Fate Therapeutics (FATE) compare with its price?

Share ↗
1 mentions

Which subreddits are talking about Fate Therapeutics (FATE)?

30 days

Which subreddits are talking about Fate Therapeutics (FATE)?
CommunityShareMentionsNet sentiment
r/wallstreetbets100%1+0.05

What do people ask about Fate Therapeutics (FATE)?

From live data
What did Fate Therapeutics shares close at?0.9246

Fate Therapeutics closed at 0.9246 USD on 20 Nov 2026, down 9.35% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Fate Therapeutics’ market cap?112.4M

Fate Therapeutics is worth 112.4M USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Fate Therapeutics’ revenue?6.6M

Fate Therapeutics reported revenue of 6.6M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Fate Therapeutics insiders bought or sold shares recently?1 sale

In the 90 days to 23 Nov 2026, Fate Therapeutics insiders reported 1 open-market sale and no purchases (SEC Form 4); the filings we hold, back to 20 Oct 2025, show no open-market purchase. See Insiders

Which funds own Fate Therapeutics?8 of 45

8 of the 45 funds we track reported a Fate Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, Renaissance Technologies and Millennium Management. See Funds

Have members of Congress traded Fate Therapeutics?1 trade

Yes. 1 trade in Fate Therapeutics appears in the congressional disclosures we hold: a sale by Daniel S. Goldman (House, NY) dated 31 Jan 2023, filed 24 Feb 2023. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did Fate Therapeutics last report earnings?−0.25

Fate Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.25 USD; no next date is announced in SEC filings yet. See Filings

What is Reddit saying about Fate Therapeutics?1 mentions

Fate Therapeutics was mentioned 1 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. Wikimedia CommonsPortraits via Wikimedia Commons. Daniel S. Goldman: US House, Public domain.
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. SECSEC fails-to-deliver (CNS) data
  9. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  10. SEC EDGARreported earnings figures and scheduled report dates
  11. SEC EDGARValuation computed from SEC EDGAR filings
  12. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words